138 related articles for article (PubMed ID: 11642505)
21. Allogeneic myeloablative transplantation for patients aged 50 years and over.
Yanada M; Emi N; Naoe T; Sakamaki H; Iseki T; Hirabayashi N; Karasuno T; Chiba S; Atsuta Y; Hamajima N; Takahashi S; Kato S
Bone Marrow Transplant; 2004 Jul; 34(1):29-35. PubMed ID: 15156161
[TBL] [Abstract][Full Text] [Related]
22. Intensive immunosuppression with autologous hematopoietic stem cell reconstitution as therapy for rheumatoid arthritis.
Klassen LW
J Rheumatol Suppl; 2001 Oct; 64():3-4. PubMed ID: 11642501
[No Abstract] [Full Text] [Related]
23. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
24. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
Craddock CF
Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
[TBL] [Abstract][Full Text] [Related]
25. Stem cell transplantation in rheumatoid arthritis.
Snowden JA; Kapoor S; Wilson AG
Autoimmunity; 2008 Dec; 41(8):625-31. PubMed ID: 18958746
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
27. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications.
Marmont AM
Best Pract Res Clin Haematol; 2004 Jun; 17(2):223-32. PubMed ID: 15302336
[TBL] [Abstract][Full Text] [Related]
28. Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases.
Kozák T; Rychlík I
Isr Med Assoc J; 2002 Apr; 4(4):268-71. PubMed ID: 12001701
[TBL] [Abstract][Full Text] [Related]
29. [Immunoablation or otherwise followed by hematopoietic cell stem as intensive treatment of severe autoimmune diseases].
du Haut Champ AM
Ann Ital Med Int; 2002; 17(1):11-20. PubMed ID: 11975110
[TBL] [Abstract][Full Text] [Related]
30. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Alousi A; de Lima M
Clin Adv Hematol Oncol; 2007 Jul; 5(7):560-70. PubMed ID: 17679930
[TBL] [Abstract][Full Text] [Related]
31. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
32. Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritis.
Tyndall A;
J Rheumatol Suppl; 2001 Oct; 64():5-7. PubMed ID: 11642506
[TBL] [Abstract][Full Text] [Related]
33. Nonmyeloablative allogeneic stem cell transplantation for acute leukemia.
Laport GG
Curr Hematol Rep; 2003 Jan; 2(1):49-56. PubMed ID: 12901154
[TBL] [Abstract][Full Text] [Related]
34. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
[TBL] [Abstract][Full Text] [Related]
35. High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation.
Passweg JR; Meyer-Monard S; Gregor M; Favre G; Heim D; Ebnoether M; Tichelli A; Gratwohl A
Bone Marrow Transplant; 2002 Sep; 30(5):267-71. PubMed ID: 12209347
[TBL] [Abstract][Full Text] [Related]
36. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
[TBL] [Abstract][Full Text] [Related]
37. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
[TBL] [Abstract][Full Text] [Related]
38. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
39. High dose therapy and autologous hemopoietic stem cell transplantation in rheumatoid arthritis--the feasibility of phase III trials.
Snowden J
J Rheumatol Suppl; 2001 Oct; 64():55-9. PubMed ID: 11642507
[TBL] [Abstract][Full Text] [Related]
40. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
